Flare therapeutics appoints douglas manion, m.d., frcp (c) as chief executive officer

Cambridge, mass. , april 23, 2024 /prnewswire/ -- flare therapeutics inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced the appointment of douglas manion, m.d.

ACRS Ratings Summary

ACRS Quant Ranking